Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.

Halasz LM, Uno H, Hughes M, D'Amico T, Dexter EU, Edge SB, Hayman JA, Niland JC, Otterson GA, Pisters KM, Theriault R, Weeks JC, Punglia RS.

Cancer. 2016 Jul 1;122(13):2091-100. doi: 10.1002/cncr.30009. Epub 2016 Apr 18.

PMID:
27088755
2.

Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome.

Matro JM, Li T, Cristofanilli M, Hughes ME, Ottesen RA, Weeks JC, Wong YN.

Clin Breast Cancer. 2015 Feb;15(1):1-7. doi: 10.1016/j.clbc.2014.05.005. Epub 2014 Jun 23.

3.

Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.

Vaz-Luis I, Ottesen RA, Hughes ME, Mamet R, Burstein HJ, Edge SB, Gonzalez-Angulo AM, Moy B, Rugo HS, Theriault RL, Weeks JC, Winer EP, Lin NU.

J Clin Oncol. 2014 Jul 10;32(20):2142-50. doi: 10.1200/JCO.2013.53.1608. Epub 2014 Jun 2.

4.

Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions.

Vandergrift JL, Niland JC, Theriault RL, Edge SB, Wong YN, Loftus LS, Breslin TM, Hudis CA, Javid SH, Rugo HS, Silver SM, Lepisto EM, Weeks JC.

J Natl Cancer Inst. 2013 Jan 16;105(2):104-12. doi: 10.1093/jnci/djs506. Epub 2012 Dec 21.

5.

Time to diagnosis and breast cancer stage by race/ethnicity.

Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH.

Breast Cancer Res Treat. 2012 Dec;136(3):813-21. doi: 10.1007/s10549-012-2304-1. Epub 2012 Oct 26.

6.

Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network.

Freedman RA, Hughes ME, Ottesen RA, Weeks JC, He Y, Wong YN, Theriault R, Keating NL.

Cancer. 2013 Feb 15;119(4):839-46. doi: 10.1002/cncr.27831. Epub 2012 Sep 25.

7.

Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.

Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, Hudis CA, Marcom PK, Pettinga JE, Share D, Theriault R, Wong YN, Vandergrift JL, Niland JC, Weeks JC.

J Clin Oncol. 2012 Jun 20;30(18):2218-26. doi: 10.1200/JCO.2011.38.5740. Epub 2012 May 14.

8.

The effect of age on delay in diagnosis and stage of breast cancer.

Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM.

Oncologist. 2012;17(6):775-82. doi: 10.1634/theoncologist.2011-0469. Epub 2012 May 3.

9.

Institutional variation in the surgical treatment of breast cancer: a study of the NCCN.

Greenberg CC, Lipsitz SR, Hughes ME, Edge SB, Theriault R, Wilson JL, Carter WB, Blayney DW, Niland J, Weeks JC.

Ann Surg. 2011 Aug;254(2):339-45. doi: 10.1097/SLA.0b013e3182263bb0.

10.

Continued use of trastuzumab beyond disease progression in the national comprehensive cancer network: should we practice ahead of the evidence?

Wong YN, Ottesen RA, Hughes ME, Niland JC, Theriault R, Edge SB, Blayney D, Weeks JC.

Oncologist. 2011;16(5):559-65. doi: 10.1634/theoncologist.2010-0360. Epub 2011 Mar 30.

11.

Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.

Hassett MJ, Hughes ME, Niland JC, Edge SB, Theriault RL, Wong YN, Wilson J, Carter WB, Blayney DW, Weeks JC.

J Clin Oncol. 2008 Dec 1;26(34):5553-60. doi: 10.1200/JCO.2008.17.9705. Epub 2008 Oct 27.

12.

Selecting high priority quality measures for breast cancer quality improvement.

Hassett MJ, Hughes ME, Niland JC, Ottesen R, Edge SB, Bookman MA, Carlson RW, Theriault RL, Weeks JC.

Med Care. 2008 Aug;46(8):762-70. doi: 10.1097/MLR.0b013e318178ead3.

13.

Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network.

Punglia RS, Hughes ME, Edge SB, Theriault RL, Bookman MA, Wilson JL, Ottesen RA, Niland JC, Weeks JC.

Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1434-40. doi: 10.1016/j.ijrobp.2008.03.020. Epub 2008 May 28.

14.

A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network.

Christian CK, Niland J, Edge SB, Ottesen RA, Hughes ME, Theriault R, Wilson J, Hergrueter CA, Weeks JC.

Ann Surg. 2006 Feb;243(2):241-9.

Items per page

Supplemental Content

Write to the Help Desk